In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

Electronic Transmission of Claims (ETC)

As contractors will be aware, as stated in the Drug Tariff to receive the recurring connectivity payment of £200pcm as of 31 March 2018 they were required to have a system compliant with Phase 2 releases 1,2 and 3 (which includes the Electronic Transmission of Claims (ETC) service).

As of 1 April 2019 the Drug Tariff will also include the following requirements:

“From June 2019, compliance with phase 2, release 3 will be assessed against the percentage of ETC claim messages submitted for qualifying prescription items. Qualifying items are defined as those prescribed on a WP10 prescription containing a 2DRx barcode. In order to retain the IM&T allowance, each contractor must submit ETC claim messages to meet the following thresholds: